Egetis Therapeutics AB (publ) (STO: EGTX)
Sweden
· Delayed Price · Currency is SEK
5.80
-0.09 (-1.53%)
Aug 30, 2024, 5:29 PM CET
Egetis Therapeutics AB Revenue
Egetis Therapeutics AB had revenue of 82.90M SEK in the quarter ending June 30, 2024, with 6.15% growth. This brings the company's revenue in the last twelve months to 305.50M, up 6.41% year-over-year. In the year 2023, Egetis Therapeutics AB had annual revenue of 292.10M with 11.23% growth.
Revenue (ttm)
305.50M
Revenue Growth
+6.41%
P/S Ratio
23.00
Revenue / Employee
2.08M
Employees
34
Market Cap
1.70B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 292.10M | 29.50M | 11.23% |
Dec 31, 2022 | 262.60M | 35.70M | 15.73% |
Dec 31, 2021 | 226.90M | 48.50M | 27.19% |
Dec 31, 2020 | 178.40M | 68.70M | 62.63% |
Dec 31, 2019 | 109.70M | 106.40M | 3,224.24% |
Dec 31, 2009 | Pro | Pro | Pro |
Dec 31, 2008 | Pro | Pro | Pro |
Dec 31, 2007 | Pro | Pro | Pro |
Dec 31, 2006 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca PLC | 520.76B |
ABB Ltd | 342.58B |
Investor AB (publ) | 240.73B |
Investor AB (publ) | 240.73B |
Atlas Copco AB | 177.12B |
Atlas Copco AB | 177.12B |
AB Volvo (publ) | 552.20B |
AB Volvo (publ) | 552.20B |